$CRXX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in EPIRUS Biopharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in EPIRUS Biopharmaceuticals, Inc.. Get notifications about new insider transactions in EPIRUS Biopharmaceuticals, Inc. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.54	3,400	1,831	8,457,999	8.5 M to 8.5 M (+0.04 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	6,000	3,279	8,454,599	8.4 M to 8.5 M (+0.07 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	2,000	1,093	8,448,599	8.4 M to 8.4 M (+0.02 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	1,800	984	8,446,599	8.4 M to 8.4 M (+0.02 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	16,000	8,800	8,444,799	8.4 M to 8.4 M (+0.19 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	4,000	2,200	8,428,799	8.4 M to 8.4 M (+0.05 %)
Dec 03 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	6,800	3,740	8,424,799	8.4 M to 8.4 M (+0.08 %)
Dec 01 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.49	4,000	1,976	8,417,999	8.4 M to 8.4 M (+0.05 %)
Dec 01 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.49	1,000	494	8,413,999	8.4 M to 8.4 M (+0.01 %)
Dec 01 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.49	1,600	790	8,412,999	8.4 M to 8.4 M (+0.02 %)
Nov 26 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.47	7,000	3,275	8,411,399	8.4 M to 8.4 M (+0.08 %)
Nov 26 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.47	2,000	936	8,404,399	8.4 M to 8.4 M (+0.02 %)
Nov 26 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.47	3,300	1,544	8,402,399	8.4 M to 8.4 M (+0.04 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	49,000	22,050	8,399,099	8.4 M to 8.4 M (+0.59 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	14,000	6,300	8,350,099	8.3 M to 8.4 M (+0.17 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	20,100	9,045	8,336,099	8.3 M to 8.3 M (+0.24 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	7,000	3,150	8,315,999	8.3 M to 8.3 M (+0.08 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	2,000	900	8,308,999	8.3 M to 8.3 M (+0.02 %)
Nov 25 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.45	3,000	1,350	8,306,999	8.3 M to 8.3 M (+0.04 %)
Nov 18 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	6,000	3,578	8,303,999	8.3 M to 8.3 M (+0.07 %)
Nov 18 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	2,000	1,193	8,297,999	8.3 M to 8.3 M (+0.02 %)
Nov 18 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	1,200	716	8,295,999	8.3 M to 8.3 M (+0.01 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	6,000	3,600	8,294,799	8.3 M to 8.3 M (+0.07 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	2,000	1,200	8,288,799	8.3 M to 8.3 M (+0.02 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	1,000	600	8,286,799	8.3 M to 8.3 M (+0.01 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	2,000	1,200	8,285,799	8.3 M to 8.3 M (+0.02 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	1,000	600	8,283,799	8.3 M to 8.3 M (+0.01 %)
Nov 14 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	600	360	8,282,799	8.3 M to 8.3 M (+0.01 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	83,000	49,659	8,282,199	8.2 M to 8.3 M (+1.01 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	23,000	13,761	8,199,199	8.2 M to 8.2 M (+0.28 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.60	33,100	19,804	8,176,199	8.1 M to 8.2 M (+0.41 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	8,000	4,640	8,143,099	8.1 M to 8.1 M (+0.10 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	2,000	1,160	8,135,099	8.1 M to 8.1 M (+0.02 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	4,000	2,320	8,133,099	8.1 M to 8.1 M (+0.05 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	65,000	37,486	8,129,099	8.1 M to 8.1 M (+0.81 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	18,000	10,381	8,064,099	8 M to 8.1 M (+0.22 %)
Nov 12 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.58	26,700	15,398	8,046,099	8 M to 8 M (+0.33 %)
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Randle John	SVP Commercial Deve ...	Option Exercise	A	3.43	44,684	153,266	44,684
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Randle John	SVP Commercial Deve ...	Option Exercise	A	3.43	10,316	35,384	10,316
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	3.43	44,687	153,276	44,687
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	3.43	10,313	35,374	10,313
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	3.43	44,685	153,270	44,685
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	3.43	10,315	35,380	10,315
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	3.43	71,093	243,849	71,093
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	3.43	16,407	56,276	16,407
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	3.43	144,581	495,913	144,581
Jul 17 2008	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	3.43	7,919	27,162	7,919
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	POPS RICHARD F	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	OSHEA WILLIAM J	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	Kauffman Michael	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	FORTUNE PATRICK J	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	Deptula Barbara	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Jun 02 2008	CRXX	EPIRUS Biopharmace ...	CRAWFORD SALLY	Director	Option Exercise	A	3.63	12,500	45,375	12,500
Apr 28 2008	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	SVP, Regulatory Aff ...	Payment of Exercise	F	3.58	1,588	5,685	18,412	20 K to 18.4 K (-7.94 %)
Jan 29 2008	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	SVP, Research	Payment of Exercise	F	5.15	2,372	12,216	65,485	67.9 K to 65.5 K (-3.50 %)
Jan 29 2008	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Payment of Exercise	F	5.15	15,875	81,756	34,125	50 K to 34.1 K (-31.75 %)
Jan 29 2008	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Payment of Exercise	F	5.15	1,985	10,223	24,015	26 K to 24 K (-7.63 %)
Jan 29 2008	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	President and CEO	Payment of Exercise	F	5.15	3,969	20,440	317,455	321.4 K to 317.5 K (-1.23 %)
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	4.57	123,694	565,282	123,694
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	4.57	18,806	85,943	18,806
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	4.57	136,200	622,434	136,200
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	4.57	13,800	63,066	13,800
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	4.57	77,352	353,499	77,352
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	4.57	20,148	92,076	20,148
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	4.57	79,606	363,799	79,606
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	4.57	17,894	81,776	17,894
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Grant	A	0.00	25,000	0	25,000	0 to 25 K
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	4.57	239,062	1,092,513	239,062
Jan 17 2008	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	4.57	15,938	72,837	15,938
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	6.47	47,280	305,902	47,280
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	6.47	2,720	17,598	2,720
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Reg. Af ...	Option Exercise	A	6.47	10,156	65,709	10,156
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Reg. Af ...	Option Exercise	A	6.47	2,344	15,166	2,344
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	6.47	18,281	118,278	18,281
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	6.47	4,219	27,297	4,219
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	6.47	20,311	131,412	20,311
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Option Exercise	A	6.47	4,689	30,338	4,689
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & Gen.Cou ...	Option Exercise	A	6.47	10,156	65,709	10,156
Jul 13 2007	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & Gen.Cou ...	Option Exercise	A	6.47	2,344	15,166	2,344
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	OSHEA WILLIAM J	Director	Option Exercise	A	6.75	25,000	168,750	25,000
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	CRAWFORD SALLY	Director	Option Exercise	A	6.75	25,000	168,750	25,000
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	Deptula Barbara	Director	Option Exercise	A	6.75	12,500	84,375	12,500
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	FORTUNE PATRICK J	Director	Option Exercise	A	6.75	12,500	84,375	12,500
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	6.75	12,500	84,375	12,500
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	Kauffman Michael	Director	Option Exercise	A	6.75	12,500	84,375	12,500
Jun 04 2007	CRXX	EPIRUS Biopharmace ...	POPS RICHARD F	Director	Option Exercise	A	6.75	12,500	84,375	12,500
May 16 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and CFO	Buy	P	7.00	1,500	10,500	1,500	0 to 1.5 K
May 16 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and CFO	Buy	P	7.00	1,500	10,500	1,500	0 to 1.5 K
May 16 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and CFO	Buy	P	7.00	1,000	7,000	26,000	25 K to 26 K (+4.00 %)
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Option Exercise	A	8.79	44,698	392,895	44,698
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Option Exercise	A	8.79	11,552	101,542	11,552
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	8.79	38,839	341,395	38,839
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Grau Daniel	Chief Operating Off ...	Option Exercise	A	8.79	11,161	98,105	11,161
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	Executive VP & CFO	Option Exercise	A	8.79	77,452	680,803	77,452
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Forrester Robert	Executive VP & CFO	Option Exercise	A	8.79	12,548	110,297	12,548
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	8.79	51,178	449,855	51,178
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	8.79	5,072	44,583	5,072
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	8.79	138,155	1,214,382	138,155
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	A	8.79	11,845	104,118	11,845
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	8.79	33,202	291,846	33,202
Jan 19 2007	CRXX	EPIRUS Biopharmace ...	BAIRD LYNN G	Senior VP - Regulat ...	Option Exercise	A	8.79	4,298	37,779	4,298
Oct 02 2006	CRXX	EPIRUS Biopharmace ...	ALDRICH RICHARD	Director	Option Exercise	A	6.11	6,786	41,462	6,786
Oct 02 2006	CRXX	EPIRUS Biopharmace ...	Deptula Barbara	Director	Option Exercise	A	6.11	6,786	41,462	6,786
Oct 02 2006	CRXX	EPIRUS Biopharmace ...	POPS RICHARD F	Director	Option Exercise	A	6.11	6,786	41,462	6,786
Oct 02 2006	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	6.11	6,786	41,462	6,786
Oct 02 2006	CRXX	EPIRUS Biopharmace ...	FORTUNE PATRICK J	Director	Option Exercise	A	6.11	6,786	41,462	6,786
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	6.04	1,200	7,248	45,714	46.9 K to 45.7 K (-2.56 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.99	700	4,193	46,914	47.6 K to 46.9 K (-1.47 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.98	1,600	9,568	47,614	49.2 K to 47.6 K (-3.25 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.96	200	1,192	49,214	49.4 K to 49.2 K (-0.40 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.95	700	4,165	49,414	50.1 K to 49.4 K (-1.40 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.94	600	3,564	50,114	50.7 K to 50.1 K (-1.18 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.93	1,700	10,081	50,714	52.4 K to 50.7 K (-3.24 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.92	500	2,960	52,414	52.9 K to 52.4 K (-0.94 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.91	1,900	11,229	52,914	54.8 K to 52.9 K (-3.47 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.90	600	3,540	54,814	55.4 K to 54.8 K (-1.08 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.89	100	589	55,414	55.5 K to 55.4 K (-0.18 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.87	100	587	55,514	55.6 K to 55.5 K (-0.18 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.86	900	5,274	55,614	56.5 K to 55.6 K (-1.59 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.83	600	3,498	56,514	57.1 K to 56.5 K (-1.05 %)
Sep 18 2006	CRXX	EPIRUS Biopharmace ...	Lessem Jan	Executive VP & CMO	Sell	S	5.82	600	3,492	57,114	57.7 K to 57.1 K (-1.04 %)
Aug 10 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Option Exercise	M	0.87	1,767	1,536	29,792
Aug 10 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Sell	S	7.00	1,767	12,369	67,857	69.6 K to 67.9 K (-2.54 %)
Aug 10 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Buy	M	0.87	1,767	1,536	69,624	67.9 K to 69.6 K (+2.60 %)
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Option Exercise	M	0.87	1,849	1,608	31,559
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Option Exercise	M	0.87	3,020	2,626	33,408
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Sell	S	7.00	1,849	12,943	67,857	69.7 K to 67.9 K (-2.65 %)
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Buy	M	0.87	1,849	1,608	69,706	67.9 K to 69.7 K (+2.72 %)
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Sell	S	7.00	3,020	21,140	67,857	70.9 K to 67.9 K (-4.26 %)
Aug 09 2006	CRXX	EPIRUS Biopharmace ...	Keith Curtis T	Senior VP, Research	Buy	M	0.87	3,020	2,626	70,877	67.9 K to 70.9 K (+4.45 %)
Jul 31 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	1.31	4,461	5,855	14,835
Jul 31 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	0.88	714	625	10,715
Jul 31 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Sell	S	7.14	5,175	36,950	50,000	55.2 K to 50 K (-9.38 %)
Jul 31 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	1.31	4,461	5,855	55,175	50.7 K to 55.2 K (+8.80 %)
Jul 31 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	0.88	714	625	50,714	50 K to 50.7 K (+1.43 %)
Aug 02 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	1.31	1,477	1,939	13,358
Aug 02 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	0.87	8,873	7,714	6,541
Aug 02 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Sell	S	7.00	10,350	72,450	50,000	60.4 K to 50 K (-17.15 %)
Aug 02 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	0.87	8,873	7,714	60,350	51.5 K to 60.4 K (+17.24 %)
Aug 02 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	1.31	1,477	1,939	51,477	50 K to 51.5 K (+2.95 %)
Aug 07 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	0.88	2,331	2,040	5,669
Aug 07 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Option Exercise	M	0.87	6,541	5,687	0
Aug 07 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Sell	S	7.00	8,872	62,104	50,000	58.9 K to 50 K (-15.07 %)
Aug 07 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	0.88	2,331	2,040	58,872	56.5 K to 58.9 K (+4.12 %)
Aug 07 2006	CRXX	EPIRUS Biopharmace ...	Grau Daniel	SVP, Commercial Ope ...	Buy	M	0.87	6,541	5,687	56,541	50 K to 56.5 K (+13.08 %)
Jul 24 2006	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Option Exercise	M	0.87	10,000	8,694	25,714
Jul 24 2006	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Sell	S	7.76	1,000	7,760	321,429	322.4 K to 321.4 K (-0.31 %)
Jul 24 2006	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Sell	S	7.73	1,000	7,730	322,429	323.4 K to 322.4 K (-0.31 %)
Jul 24 2006	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Sell	S	7.71	1,000	7,710	323,429	324.4 K to 323.4 K (-0.31 %)

Page: < prev 1 2 3 4 5 next >